Loading patent…
AssigneeFaron Pharmaceuticals Oy
InventorsSirpa Jalkanen, Marko Salmi, Markku Jalkanen
Estimating the term…
The present invention relates to a method for treatment or prevention of metabolic syndrome and diseases or conditions resulting therefrom in an individual in which an effective amount of an amine oxidase enzyme inhibitor is administered to the individual. The invention also relates to a method for inhibiting an amine oxidase enzyme or for treatment or prevention of diseases or conditions benefiting from inhibition of an amine oxidase enzyme in an individual in which a vitamin B1, its derivative, its precursor or metabolite is administered to the individual. In addition, the invention relates to a food product comprising an amine oxidase enzyme inhibitor in combination with a foodstuff, as well as a food additive comprising an amine oxidase enzyme inhibitor in combination with a liquid, solid or semisolid carrier.
A method for treatment or prevention of metabolic syndrome or diseases or conditions resulting therefrom in an individual, said method comprising administering of an effective amount of an amine oxidase enzyme inhibitor to said individual.
A method for inhibiting an amine oxidase enzyme or for treatment or prevention of diseases or conditions benefiting from inhibition of an amine oxidase enzyme in an individual, said method comprising administering of an effective amount of a vitamin B1, its derivative, its precursor or metabolite to said individual.
A food product comprising an amine oxidase enzyme inhibitor in combination with a foodstuff.
A food additive comprising an amine oxidase enzyme inhibitor in combination with a liquid, solid or semisolid carrier.
Dependencies are inferred from the claim text.